SEOUL, South Korea, Aug. 29, 2025 /PRNewswire/ — Smilegate announced on Friday, August 29, that it has launched a special website for Tokyo Game Show 2025 (TGS 2025), taking place from September 25 to 28 at Makuhari Messe in Chiba, Japan. The site spotlights Smilegate’s upcoming RPGs: Chaos Zero Nightmare (CZN) and MIRESI: Invisible Future (MIRESI).
On the special site, Smilegate has unveiled official TGS 2025 participation details and key visuals for CZN and MIRESI. Additional information such as booth location and player programs will be announced as the event approaches.
CZN is Smilegate’s next-generation IP, helmed by Hyung-seok Kim, creator of Epic Seven. The game blends collectible RPG character growth with a roguelite card battle system, offering a fresh twist on the subculture RPG space.
Developer Super Creative has invested significant resources into character and background design to push the visual quality of its 2D graphics. The title is slated for global release in Q4 2025 on PC and mobile.
MIRESI is a collectible RPG in development at Control 9, targeting release next year. With striking character designs and a storyline that crosses time and space, the game aims to deliver a distinctive experience. Acclaimed illustrator Hyung-seop “Hyulla” Kim serves as Art Director, heightening anticipation.
To celebrate the site launch, Smilegate is hosting follow-and-repost events through the official Japanese X accounts for CZN and MIRESI, with TGS 2025 admission tickets given away to selected participants.
Paek, Young Hoon, CEO of Smilegate Megaport, commented: “This marks the global debut of CZN and MIRESI, so we are preparing a range of programs and on-site events to provide attendees with a truly memorable experience.”
More information on Smilegate’s TGS 2025 booth can be found on the special site (http://tgs.onstove.com/en/2025).
SOURCE Smilegate
BUENOS AIRES, ARGENTINA, MARCH 31, 2026 ― When the Teatro Colón opens its doors to…
Creative Technology Group, Inc. (CT), the NEP Live Events group, has invested in multiple Analog…
AiGS will leverage n8n's platform to deliver future-ready automation solutions that streamline operations and unlock…
First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinical efficacy and a favorable GLP safety…
PHOENIX, AZ / ACCESS Newswire / March 31, 2026 / 1606 Corp. (OTCID:CBDW) ("1606" or…
Company Invites Investors to Submit Questions to be Answered on the Webcasted Earnings Call TORONTO,…